2024-05-28 06:47:51 ET
Summary
- Lexicon Pharmaceuticals has a strong cash position and multiple late-stage assets.
- However, the company is facing low revenues and high expenses.
- Overall, Lexicon Pharmaceuticals' financial situation presents a mixed outlook for the company.
This is my first look at Lexicon Pharmaceuticals ( LXRX ). I am intrigued by its nice cash, its one approved and several late-stage assets. I am disheartened by its measly revenues and its hefty expenses. Its overall story highlights another tough day in pharma land for sure....
Read the full article on Seeking Alpha
For further details see:
Lexicon Pharmaceuticals: Blue Sky Aplenty, Revenue Not So Much